WVSHP Logo Contact Information
News & Events

News from WVSHP

POCT Certificate Program

The University of Charleston School of Pharmacy will host a pharmacist training session on May 11th from 1-5 PM.  The program will provide the “Community Pharmacy-Based Point-of-Care Testing (POCT) Certificate Program” through the NACDS organization.
Specifics from NACDS include:
-Practical, hands-on training in point-of-care testing in four (4) disease states
-20 credit hours of ACPE-accredited continuing education
-Unique dual home study and in-person structure
-Access to and training on the interactive, web-based education platform
The cost will be:
    $400 for pharmacists
    $300 for UC alumni and preceptors
    $250 for any current UCSOP students
Contact Gannett Monk with any questions at gannettmonk@ucwv.edu, or to request the UC alumni/preceptor/student discount code.
To sign up, go to:  http://www.ucwv.edu/POCT/ 


ASHP and ACPE revised guidelines ASHP and the Accreditation Council for Pharmacy Education (ACPE) just released revisions to the Accreditation Standards for Pharmacy Technician Educat (Click for more...)

News from elsewhere...
New PM urges action to improve vaccination uptake 8/19/2019 11:23:16 AM The UK has lost its ‘measles-free’ status with WHO, just three years after the virus was eliminated in the country. (Click for more...) Researchers develop ‘highly sensitive’ breast cancer blood test 8/19/2019 8:04:22 AM Researchers found that the test was able to identify circulating tumour DNA in every patient before they started treatment. (Click for more...) Health leaders call on PM to ‘end crisis in care’ 8/19/2019 7:58:50 AM Swingeing cuts in social care that have left around 1.4 million older people in England unable to access the care and support they need. (Click for more...) Rinvoq bags FDA green light 8/19/2019 7:48:22 AM In the SELECT programme, the oral JAK inhibitor met all primary and ranked secondary endpoints across a variety of rheumatoid arthritis patients. (Click for more...) Rozlytrek bags FDA approval 8/16/2019 7:39:11 AM For the indication of ROS1-positive, metastatic non-small cell lung cancer (NSCLC). (Click for more...) £500,000 injected into ‘innovative’ AI online safety software 8/16/2019 7:32:16 AM UK Meds has announced a partnership with Onfido to make buying prescription-only medicines online much safer. (Click for more...) Terlipressin hits phase III endpoint 8/16/2019 7:29:43 AM CONFIRM is the largest-ever prospective study conducted in patients with hepatorenal syndrome type I. (Click for more...) Government to reconsider NHS Health Checks 8/16/2019 7:21:13 AM The Health and Social Care Secretary has announced an evidence-based review into the service. (Click for more...) NHS toolkit launched for progressive neurological conditions 8/16/2019 6:57:37 AM The NHS estimates there could be 2,500 fewer emergency admissions to hospital a year for patients with progressive neurological conditions. (Click for more...) ‘Probe’ could help make prostate cancer surgery more accurate 8/15/2019 7:05:14 AM The new project could ‘help surgeons to visualise tumours during keyhole surgery’. (Click for more...) Urgent medical delivery service set up in Brexit preparations 8/15/2019 6:59:33 AM The £25 million contract to set up an express freight service aims to be completed in the next one to four days. (Click for more...) Evinacumab hits targets in late-stage cholesterol trial 8/15/2019 6:50:12 AM On average patients entered the trial with LDL cholesterol levels of 255 mg/dL, despite treatment with other lipid-lowering therapies. (Click for more...) Taltz trumps Tremfya in plaque psoriasis study 8/15/2019 6:41:54 AM The drug met the primary and all major secondary endpoints up to week 12 in the Phase IV IXORA-R study. (Click for more...) Marketer of the Year finalists share their experiences with the competition 8/15/2019 4:05:00 AM Now in its 26th year, this prestigious competition has a long history of discovering and rewarding the very best healthcare marketers and last year was no exception. (Click for more...) Ebola ‘no longer incurable’ 8/14/2019 7:33:46 AM Two new drugs, mAb114 and REGN-EB3, have been found to dramatically cut mortality from Ebola. (Click for more...)
Copyright© 2019 West Virginia Society of Health System Pharmacists. All rights reserved.